New Zealand markets closed

Daxor Corporation (DXR)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
9.20+0.49 (+5.63%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close8.71
Open9.20
Bid0.00 x 0
Ask0.00 x 0
Day's range9.20 - 9.20
52-week range7.11 - 10.15
Volume188
Avg. volume1,543
Market cap44.5M
Beta (5Y monthly)-0.53
PE ratio (TTM)65.71
EPS (TTM)0.14
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend date05 Jan 2018
1y target est23.25
  • GlobeNewswire

    Daxor Corporation’s BVA-100™ Blood Volume Diagnostic Expands to Three New Centers, Gains Traction Nationwide

    Daxor's ezBVA Lab Service Emerges as Key Driver for Expansion and Market Penetration Oak Ridge, TN, July 11, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces the expansion of blood volume analysis (BVA). This growth includes launching a BVA program and increasing adoption of Daxor's ezBVA Lab service - a state-of-the-art CLIA certified facility that provides on-demand, next day blood volume analysis results. The c

  • GlobeNewswire

    Daxor Corporation to Showcase the Benefits of BVA-100™ Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 20th Annual Meeting

    Oak Ridge, TN, June 18, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today it will exhibit at the American Association of Heart Failure Nurses (AAHFN) 20th Annual Meeting from June 20-22nd, 2024 at the Rosen Shingle Creek Resort in Orlando, Florida. The AAHFN is a specialty organization dedicated to advancing nursing education, clinical practice, and research to improve heart failure patient outcomes. "The AAHFN Ann

  • GlobeNewswire

    Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer

    Oak Ridge, TN, June 05, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces the appointment of Dr. John L. Jefferies, M.D., M.B.A., M.P.H., F.A.C.C., F.A.H.A., F.A.A.P., F.H.F.S.A., F.E.S.C., F.R.C.P.E., as Chief Medical Officer. As part of his new responsibilities, Dr. Jefferies will leverage his extensive expertise to advise Daxor on strategic clinical and medical affairs matters and to facilitate the collaboration